<p>In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug</p>

Abstract

The formulation F₁₀ demonstrated a comparatively more delayed rate of release with enhanced dissolution as compared to a single surfactant scheme. The F₁₀ formulation can be a remarkable nanotechnology for prolonged delivery of CsA orally with improved dissolution profile and bioavailability.